THIS ISSUE OF THE JOURNAL OF URBAN HEALTH
In this issue of the Journal, the topic is end-of-life and palliative care for patients with AIDS in the era of highly active antiretroviral therapy (HAART). For urban areas severely affected by the epidemic of AIDS, enormous efforts before the availability of HAART were focused on primary prevention of HW infection through education and counseling and the prophylaxis and treatment of opportunistic infections. With the advent of HAART, dramatic improvements in many patients have been reported. A feeling of optimism that HIV might be controlled and managed began to develop. Now, we are learning that response to these new therapies is variable, relating in part to issues around adherence, drug resistance, and host factors. End-oflife issues have not disappeared for HIV infection. Rather, these issues require reexamination in the era of HA.ART. New information will be needed to learn how these new therapies alter the course and manifestations of HIV infection, the patients' abilities to cope with infection, and the effective management of symptoms in response to the newer therapies.
In this issue, Dr. Peter A. Selwyn, as a special editor, brings together a number of papers that address the concerns of end-of-life issues and palliative care in the era of HAART. While much attention in the literature is now directed toward promoting access and adherence to combination antiretroviral therapies, these papers provide important insights into addressing the needs of patients throughout the entire course of HIV infection.
The original papers are organized into review, epidemiological, clinical observation, and government perspectives. The New York City Department of Health column provides data relating to the trends in mortality in the era of HAART.
Finally, a historical paper from the Bulletin demonstrates that the tension between palliative and curative care has existed in different forms for some time. 
